SYI_WOLTR
ID SYI_WOLTR Reviewed; 1134 AA.
AC Q5GSS3;
DT 20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT 01-MAR-2005, sequence version 1.
DT 03-AUG-2022, entry version 108.
DE RecName: Full=Isoleucine--tRNA ligase {ECO:0000255|HAMAP-Rule:MF_02003};
DE EC=6.1.1.5 {ECO:0000255|HAMAP-Rule:MF_02003};
DE AltName: Full=Isoleucyl-tRNA synthetase {ECO:0000255|HAMAP-Rule:MF_02003};
DE Short=IleRS {ECO:0000255|HAMAP-Rule:MF_02003};
GN Name=ileS {ECO:0000255|HAMAP-Rule:MF_02003}; OrderedLocusNames=Wbm0363;
OS Wolbachia sp. subsp. Brugia malayi (strain TRS).
OC Bacteria; Proteobacteria; Alphaproteobacteria; Rickettsiales;
OC Anaplasmataceae; Wolbachieae; Wolbachia; unclassified Wolbachia.
OX NCBI_TaxID=292805;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC STRAIN=TRS;
RX PubMed=15780005; DOI=10.1371/journal.pbio.0030121;
RA Foster J., Ganatra M., Kamal I., Ware J., Makarova K., Ivanova N.,
RA Bhattacharyya A., Kapatral V., Kumar S., Posfai J., Vincze T., Ingram J.,
RA Moran L., Lapidus A., Omelchenko M., Kyrpides N., Ghedin E., Wang S.,
RA Goltsman E., Joukov V., Ostrovskaya O., Tsukerman K., Mazur M., Comb D.,
RA Koonin E., Slatko B.;
RT "The Wolbachia genome of Brugia malayi: endosymbiont evolution within a
RT human pathogenic nematode.";
RL PLoS Biol. 3:599-614(2005).
CC -!- FUNCTION: Catalyzes the attachment of isoleucine to tRNA(Ile). As IleRS
CC can inadvertently accommodate and process structurally similar amino
CC acids such as valine, to avoid such errors it has two additional
CC distinct tRNA(Ile)-dependent editing activities. One activity is
CC designated as 'pretransfer' editing and involves the hydrolysis of
CC activated Val-AMP. The other activity is designated 'posttransfer'
CC editing and involves deacylation of mischarged Val-tRNA(Ile).
CC {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- CATALYTIC ACTIVITY:
CC Reaction=ATP + L-isoleucine + tRNA(Ile) = AMP + diphosphate + L-
CC isoleucyl-tRNA(Ile); Xref=Rhea:RHEA:11060, Rhea:RHEA-COMP:9666,
CC Rhea:RHEA-COMP:9695, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC ChEBI:CHEBI:58045, ChEBI:CHEBI:78442, ChEBI:CHEBI:78528,
CC ChEBI:CHEBI:456215; EC=6.1.1.5; Evidence={ECO:0000255|HAMAP-
CC Rule:MF_02003};
CC -!- COFACTOR:
CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC Evidence={ECO:0000255|HAMAP-Rule:MF_02003};
CC -!- SUBUNIT: Monomer. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- DOMAIN: IleRS has two distinct active sites: one for aminoacylation and
CC one for editing. The misactivated valine is translocated from the
CC active site to the editing site, which sterically excludes the
CC correctly activated isoleucine. The single editing site contains two
CC valyl binding pockets, one specific for each substrate (Val-AMP or Val-
CC tRNA(Ile)). {ECO:0000255|HAMAP-Rule:MF_02003}.
CC -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC IleS type 2 subfamily. {ECO:0000255|HAMAP-Rule:MF_02003}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; AE017321; AAW70951.1; -; Genomic_DNA.
DR RefSeq; WP_011256561.1; NC_006833.1.
DR AlphaFoldDB; Q5GSS3; -.
DR SMR; Q5GSS3; -.
DR STRING; 292805.Wbm0363; -.
DR PRIDE; Q5GSS3; -.
DR EnsemblBacteria; AAW70951; AAW70951; Wbm0363.
DR KEGG; wbm:Wbm0363; -.
DR eggNOG; COG0060; Bacteria.
DR HOGENOM; CLU_001493_1_1_5; -.
DR OMA; KMMAPFT; -.
DR OrthoDB; 32262at2; -.
DR Proteomes; UP000000534; Chromosome.
DR GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR GO; GO:0002161; F:aminoacyl-tRNA editing activity; IEA:InterPro.
DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR GO; GO:0004822; F:isoleucine-tRNA ligase activity; IEA:UniProtKB-UniRule.
DR GO; GO:0000049; F:tRNA binding; IEA:InterPro.
DR GO; GO:0008270; F:zinc ion binding; IEA:UniProtKB-UniRule.
DR GO; GO:0006428; P:isoleucyl-tRNA aminoacylation; IEA:UniProtKB-UniRule.
DR CDD; cd07961; Anticodon_Ia_Ile_ABEc; 1.
DR Gene3D; 3.40.50.620; -; 2.
DR HAMAP; MF_02003; Ile_tRNA_synth_type2; 1.
DR InterPro; IPR001412; aa-tRNA-synth_I_CS.
DR InterPro; IPR002300; aa-tRNA-synth_Ia.
DR InterPro; IPR033709; Anticodon_Ile_ABEc.
DR InterPro; IPR002301; Ile-tRNA-ligase.
DR InterPro; IPR023586; Ile-tRNA-ligase_type2.
DR InterPro; IPR013155; M/V/L/I-tRNA-synth_anticd-bd.
DR InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR InterPro; IPR009008; Val/Leu/Ile-tRNA-synth_edit.
DR PANTHER; PTHR42780; PTHR42780; 1.
DR Pfam; PF08264; Anticodon_1; 1.
DR Pfam; PF00133; tRNA-synt_1; 1.
DR PRINTS; PR00984; TRNASYNTHILE.
DR SUPFAM; SSF47323; SSF47323; 2.
DR SUPFAM; SSF50677; SSF50677; 1.
DR PROSITE; PS00178; AA_TRNA_LIGASE_I; 1.
PE 3: Inferred from homology;
KW Aminoacyl-tRNA synthetase; ATP-binding; Cytoplasm; Ligase; Metal-binding;
KW Nucleotide-binding; Protein biosynthesis; Zinc.
FT CHAIN 1..1134
FT /note="Isoleucine--tRNA ligase"
FT /id="PRO_0000098573"
FT MOTIF 52..62
FT /note="'HIGH' region"
FT MOTIF 656..660
FT /note="'KMSKS' region"
FT BINDING 659
FT /ligand="ATP"
FT /ligand_id="ChEBI:CHEBI:30616"
FT /evidence="ECO:0000255|HAMAP-Rule:MF_02003"
SQ SEQUENCE 1134 AA; 131811 MW; A3EDE2284B90E9B1 CRC64;
MKPKHYPDTI SSPDFSSLEK EIIKFWQENK IFEQSVEKRS KDNCFVFYDG PPFANGLPHY
GHLLTGFIKD AFARYQTMLQ KKVERRFGWD CHGLPAEMGA EKELGISGRT EIEKFGIEKF
NNYCRTSVMK FSSEWEKYVN RQARWVDFHN DYKTMDRSFM ESVIWAFKQL YDKGLVYESV
RVVPYSWACE TPLSNFETRL DTAYRKKTSK AVTVAFELLE NPQQFKQKCK LLAWTTTPWT
LPSNLALAIG KDIEYCAVSV HSSVSFQHVT LESREKETWI PLSRTGMTEE GTETVTEDNE
VSLVNNEIYI FAEDYLEKFI GHCEQNNIPY ENCNTKLKAD DLAGLSYKPL FNYFKGTKNA
FRVFIADYVT GEDGTGVVHT APGFGEEDFY LCQSHDIPAI CPIDNSGRFT AEVSDLTGIH
VFDTNDAIIK KLKEQGNWFK TEQYIHNYPH CWRTDTPLIY RAMPSWYVAV TKFKERMIEL
NKRVNWIPTH IRDGQFGKWL ERAHDWSISR NRFWGTPIPI WKSDNARYPR VDVYGSIAEL
ERDFNVKVND LHRPFIDSLT RPNPDDPTGK SIMRRVPDVF DCWFESGSVP FAQVHYPFEN
KEWFESNFPA DFITEYIAQT RGWFYTLFVL STALFDSEPF KNCICHGVVL DVKGQKLSKR
LNNYADPMEV FDKYGSDALR FLMLSGSIVC GGNLFLNKEG SSIRDVLKNV MKPIWNSYHF
FTMYANADGI KAEVCKDYKS TIDSYMIFKC FEAVESIQAS MSNYNSQEAC KILIDFFEVL
NNWYIRRSRE RFWKSNLDQD KTDAYNVLYT VFYYILRAAV PLLPLITETI WQGLKYKEIS
VHLADFPQLE RYDSELIAKM DLVREICNSA LSIRNTFNIR VRQPLGSMTV YHQSSCSFLE
SKPLSVVIPK FSPVIPMRDT GTQKEKKWSN AEMKTSMNEY QEMIKDEVNV KELKLVNSLE
GIASLELKLN FPMLGKRIPD KVKKLVQYVK EGKWKQVDNE QVFLGNESES YIIEKDEYEL
LLKTNSEYSS VFGDNKGIVI LNTALDDALV LEGLARDVVR LIQEARKQAD FHISDRIRVI
IKTEDEKIKR AINTWGEYIR EQTLSLSLEI NIEIGDNFYS KEYQDLIVGI ELNC